BioSpace

M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy

After a frantic second quarter, M&A steadied with just under $30 billion across 22 total transactions, according to a BioSpace analysis.

Por BioSpace

1 minuto de lectura
Compartir
M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy
M&A slows in Q3 but Vertex snags one of the year’s biggest in $10B Crinetics buy

¿Tiene noticias que compartir con el sector de eventos?

Envíe un comunicado de prensa o una noticia y llegue a miles de profesionales del sector de eventos.

Contáctenos→

Más en Health Tech

Perspectivas relacionadas